Pooled data show that higher apnea-hypopnea index (AHI) tracks with lower DTI-ALPS values, an MRI proxy for glymphatic transport, with a moderate correlation (r=-0.53, 95% CI -0.63 to -0.41, p<0.001) across obstructive sleep apnea studies. Meta-analyses of sleep deprivation and narcolepsy type 1 found no statistically significant glymphatic alterations, though the authors flag insufficient evidence rather than proof of absence. Heterogeneity across studies was substantial.
The finding fits a growing hypothesis that sleep is when the brain flushes metabolic waste, including amyloid-beta, and that fragmented or hypoxic sleep may impair this process. Still, DTI-ALPS is an indirect, contested measure: it captures water diffusion along perivascular spaces and can be influenced by white-matter architecture, so it does not directly show waste clearance. The correlations are cross-sectional, meaning they cannot establish that apnea causes glymphatic failure, nor that glymphatic failure drives cognitive decline; the cognitive link remains inferred. The null results for sleep deprivation may reflect small, methodologically inconsistent studies, and preclinical data was pooled alongside clinical work. For adults, the practical message is modest but consistent with existing evidence: untreated sleep apnea is associated with cognitive and dementia risk, so snoring, witnessed pauses in breathing, or daytime sleepiness are worth raising with a doctor. Whether CPAP restores glymphatic function remains untested here. This is a preprint that has not yet undergone peer review, and its conclusions may change. Editorially, it is incremental: it strengthens a plausible mechanism without demonstrating clinical benefit.